Form 4: Strata Critical Medical Co-CEO Exercises Stock Options

Strata Critical Medical Co-CEO and General Counsel Melissa M. Tomkiel acquired 27,778 shares of Class A common stock through option exercise.

Summary

• Melissa M. Tomkiel, Co-CEO, General Counsel, and Director of Strata Critical Medical, Inc. (SRTA), acquired 27,778 shares of Class A common stock.
• The transaction occurred on November 7, 2025, through the exercise of a stock option at a price of $0.18 per share.
• Following this transaction, Tomkiel directly beneficially owns 1,400,420 shares of Class A common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Tomkiel also holds 276,960 derivative securities (stock options) directly after this transaction, with an exercise price of $0.18 and an expiration date of July 28, 2030.

Sentiment

Score: 7

Explanation: The exercise of stock options by a high-ranking insider, especially under a 10b5-1 plan, generally indicates a planned increase in ownership, which can be viewed positively as a sign of confidence in the company's long-term prospects. No negative information was disclosed.

Positives

• An insider, the Co-CEO and General Counsel, increased her direct ownership in the company, which can signal confidence in future performance.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled, non-discretionary transaction.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which focuses solely on an insider transaction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• This filing details an insider transaction where a Co-CEO and Director acquired shares from the company through option exercise, which is inherently a related party transaction under Section 16 reporting requirements.

Stakeholder Impact

• Shareholders: Increased insider ownership may be perceived as a positive signal of management's confidence in the company's future value.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction involving the exercise of stock options under a pre-arranged 10b5-1 plan. While insider buying can be a positive signal, this specific transaction is an option exercise, not open market buying, and is part of a pre-scheduled plan. It does not provide new fundamental information to warrant a change in investment recommendation, thus a 'hold' stance is maintained.

Keywords

Strata Critical Medical, SRTA, Insider Trading, Form 4, Stock Option Exercise, Melissa M. Tomkiel, Beneficial Ownership, Rule 10b5-1